Subscribe to
this category
r

Business

A total of 148 posts are filed under Business
ICER Analysis Finds Spark Gene Therapy Priced Too High
Rare Daily Staff The Institute for Clinical and Economic Review, an independent non-profit research institute that analyzes the evidence on… Continue Reading
Global Genes Rare Disease Stock Index Rises 2.88% During JPMorgan Week
The Global Genes Rare Disease Stock Index finished the week up 2.88 percent as investors focused on what was a suprisingly light news flow… Continue Reading
Pharnext Takes a Unique Twist on Repurposing Drugs for Rare Diseases
Repurposing, finding new uses for already approved drugs, has long been viewed as a way bring needed therapies to rare disease patients… Continue Reading
Ablynx Board Says Novo Nordisk’s Unsolicited $3.1 Billion Bid Undervalues It
Rare Daily Staff Rare disease drug developer Ablynx, which is developing a new class of drugs dubbed “nanobodies,” said it received an… Continue Reading
Retrophin Enters PKU Collaboration with Censa, Gets Option to Acquire Company
Rare Daily Staff Retrophin said it will make an upfront payment of $10 million with Censa Pharmaceuticals as part of a joint development… Continue Reading
uniQure Seeks to Find Elusive Market Success with Hemophilia B Gene Therapy
uniQure achieved a milestone when it won approval in Europe for Glybera, the first gene therapy approved in the Western World, but it later… Continue Reading
Global Genes Rare Disease Stock Index Rises 0.28% As New Year Begins
The Global Genes Rare Disease Stock Index finished a holiday-shortened first week of trading in the nuew year up 0.28 percent. All of the… Continue Reading